Wuhan Tallyho Biological Products Co., Ltd., as a benchmark enterprise in Asia's health industry, has been focusing on the research and development and innovative application of peptide technology for 30 years, and it integrates raw material production, product development, intelligent manufacturing and global sales. The company integrates molecular nutrition, epigenetics, and the theory of "homology of traditional Chinese medicine and food." It has pioneered the "peptide-benefit synergy" technology, achieved significant breakthroughs in the
field of synergistic effects between functional peptides and probiotics, holds a number of national patents, and continues to drive the development of the precision nutrition industry.
The company innovatively integrates AI intelligent screening and living cell targeting technology to accurately analyze amino acid sequences and prepare high-purity functional peptides through enzymatic digestion. Relying on the big data analysis engine, the company intelligently identified market demand, built a differentiated product matrix, and successfully developed a number of best-selling health products.
Adhering to the spirit of "specialized and excellent", the company's products have served 170 million consumers worldwide. In the future, the company will continue to deepen the strategy of "internationalization of scientific research + digitalization of industry" to benefit the world with China's intelligent health solutions.